---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-000296"
form_type: "8-K"
ticker: "BNGO"
cik: "0001411690"
company_name: "Bionano Genomics, Inc."
filed_at: "2025-01-06T23:59:59+00:00"
generated_at: "2026-05-28T10:12:31.264749+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Bionano Genomics raises $10M in registered direct offering of ~39.7M shares and warrants

## Summary
- Aggregate gross proceeds of ~$10M from sale of 22.9M common shares and 16.78M pre-funded warrants at $0.252/unit.
- Each share/pre-funded warrant includes a purchase warrant exercisable at $0.252; warrants require stockholder approval, expire in 5 years.
- Closing expected on January 6, 2025; H.C. Wainwright serves as placement agent with 6% cash fee.
- Net proceeds to be used for working capital, R&D, debt repayment or redemption, and capital expenditures.

## SEC filing metadata
- accession: 0001140361-25-000296
- form_type: 8-K
- ticker: BNGO
- cik: 0001411690
- company_name: Bionano Genomics, Inc.
- filed_at: 2025-01-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411690/000114036125000296/0001140361-25-000296-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411690/000114036125000296/ny20041129x2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-000296
- JSON: https://secwatch.observer/filing/0001140361-25-000296.json
- Plain text: https://secwatch.observer/filing/0001140361-25-000296.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.